ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,599,402 | -51.0% | 126,862 | -52.5% | 0.01% | -63.2% |
Q2 2023 | $5,302,429 | +213.8% | 266,856 | +170.5% | 0.02% | +171.4% |
Q1 2023 | $1,689,857 | +123.5% | 98,649 | +79.6% | 0.01% | +16.7% |
Q2 2022 | $756,000 | +52.1% | 54,935 | +75.3% | 0.01% | +50.0% |
Q1 2022 | $497,000 | -19.6% | 31,345 | +10.7% | 0.00% | -20.0% |
Q4 2021 | $618,000 | +2.0% | 28,316 | +107.4% | 0.01% | -50.0% |
Q1 2021 | $606,000 | +146.3% | 13,650 | +26.1% | 0.01% | +25.0% |
Q4 2019 | $246,000 | – | 10,826 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |